Vaxart, Inc. (OTCQX: VXRT) (“Vaxart”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that it ...

Reverba Global, a leader in scientific engagement for biopharma companies, today announced the launch of ClinOps G.P.S.™ (Global Performance Solution), an operations platform of integrated technology ...

A live webcast and additional information about the presentation can be accessed on the Events & Presentations section of the Phathom website at ...

These upcoming presentations underscore the breadth and versatility of our ACT-UP1 platform,” said Xuehai Liang, Ph.D., Chief Executive Officer of Arnatar Therapeutics. “By demonstrating the ability ...

VLTR-559 was well tolerated at target clinical dose with a safety profile similar to approved short-acting anti-VEGF therapies for wet AMD Data featured in an oral presentation at the at the ...

The event will take place on November 3, 2025 beginning at 10 am ET and will feature presentations by ProQR Management and Key Opinion Leader Professor Henkjan J. Verkade, MD, PhD, a pediatric ...

The Connect Venture List ( https://connect.org/sd-funding-news/#vc-firms) offers a transparent, living snapshot of the venture ecosystem supporting startups across technology, life sciences, defense, ...

Certara has maintained its leadership in the multidisciplinary field of pharmacology and pharmacokinetics since the inaugural list. This year, the following Certara researchers appeared on ...

Event: LD Micro Main Event XIX Date: Tuesday, October 21st Time: 11:30 ...

R1 (“R1” or the “Company”), the leader in healthcare revenue management, today announced a strategic partnership with Sierra, the leading AI-powered customer experience platform. This partnership ...